ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2021

One Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diabetes Mellitus.

Stefano Radellini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.